fermer
New posters presented at the
GERPAC
Congress 2024
has been included in the section
"Posters"
!
viimane versioon :
21/10/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 612
tüüp :
ajaleht
uurimisrühmad :
Indianapolis - Eli Lilly and Company, Lilly Research Laboratories
Autor :
Frable RA, Klink PR, Engel GL, Mundell EE.
pealkiri :
Stability of cefamandole nafate injection with parenteral solutions and additives.
publikatsioon :
Am J Hosp Pharm ; 39: 622-627. 1982
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Calcium gluconate
+
Cefamandole nafate
2 >> 100 mg/ml
+
Cefamandole nafate
2 & 20 mg/ml
25°C
72
2 & 20 mg/ml
5°C
7
285 mg/ml
25°C
72
285 mg/ml
5°C
10
285 mg/ml
25°C
72
285 mg/ml
5°C
10
285 mg/ml
25°C
72
285 mg/ml
5°C
10
20 mg/ml
25°C
72
20 mg/ml
5°C
7
2 >> 100 mg/ml
+
Calcium gluconate
+
2 >> 100 mg/ml
+
Gentamicin sulfate
+
285 mg/ml
+
Lidocaine hydrochloride
5 >> 20 mg/ml
+
2 >> 100 mg/ml
+
Tobramycin sulfate
+
2 mg/ml
+
Gentamicin sulfate
+
Cefamandole nafate
2 >> 100 mg/ml
+
Lidocaine hydrochloride
5 >> 20 mg/ml
+
Cefamandole nafate
285 mg/ml
+
Tobramycin sulfate
+
Cefamandole nafate
2 >> 100 mg/ml
+
Mentions Légales